Constitutive membrane association potentiates activation of Bruton tyrosine kinase

被引:0
|
作者
Tianjian Li
David J Rawlings
Hyunsun Park
Roberta M Kato
Owen N Witte
Anne B Satterthwaite
机构
[1] Molecular Biology Institute,Department of Pediatrics, Division of Immunology/Rheumatology
[2] University of California,Department of Microbiology and Molecular Genetics
[3] School of Medicine,undefined
[4] University of California,undefined
[5] Howard Hughes Medical Institute,undefined
[6] University of California,undefined
[7] University of California,undefined
来源
Oncogene | 1997年 / 15卷
关键词
Btk; pleckstrin homology domain; membrane targeting; transformation;
D O I
暂无
中图分类号
学科分类号
摘要
Mutations in the nonreceptor tyrosine kinase Btk result in the B cell immunodeficiencies X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. Genetic and biochemical evidence implicates Btk as a key component of several B cell signaling pathways. Activation of Btk by a point mutation (E41K) within the PH domain (Btk*) results in fibroblast transformation and is correlated with increased membrane localization of Btk. When wild type Btk is activated by coexpression with Lyn, the tyrosine phosphorylated pool of Btk is highly enriched in the membrane fraction. To determine whether membrane association is sufficient to activate Btk, we targeted Btk to the plasma membrane using a series of fusion proteins including GagBtk, CD16Btk and CD4Btk. Constitutive membrane association greatly enhanced the ability of Btk to transform Rat2 fibroblasts in the presence of high levels of Src activity. All membrane targeted forms of Btk were highly tyrosine phosphorylated. Transformation required membrane localization, Btk kinase activity, transphosphorylation by Src family kinases, and an intact SH2 domain but not the PH or SH3 domains. These data suggest that membrane localization is a critical early step in Btk activation.
引用
收藏
页码:1375 / 1383
页数:8
相关论文
共 50 条
  • [21] Involvement of Ras in Bruton's tyrosine kinase-mediated JNK activation
    Deng, JB
    Kawakami, Y
    Hartman, SE
    Satoh, T
    Kawakami, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) : 16787 - 16791
  • [22] BRUTON'S TYROSINE KINASE INHIBITION TO SUPPRESS MAST CELL ACTIVATION IN ATHEROSCLEROSIS
    Hemme, E.
    Delfos, L.
    Depuydt, M. A. C.
    Kleijn, M. N. A. Bernabe
    Schaftenaar, F. H.
    Foks, A. C.
    Kuiper, J.
    Bot, I.
    ATHEROSCLEROSIS, 2022, 355 : E100 - E100
  • [23] Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate
    Wang, Qi
    Vogan, Erik M.
    Nocka, Laura M.
    Rosen, Connor E.
    Zorn, Julie A.
    Harrison, Stephen C.
    Kuriyan, John
    ELIFE, 2015, 4
  • [24] Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors
    Wahl, MI
    Fluckiger, AC
    Kato, RM
    Park, H
    Witte, ON
    Rawlings, DJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) : 11526 - 11533
  • [25] Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells
    Várnai, P
    Rother, KI
    Balla, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) : 10983 - 10989
  • [26] Bruton's tyrosine kinase (Btk) - the critical tyrosine kinase in LPS signalling?
    Jefferies, CA
    O'Neill, LAJ
    IMMUNOLOGY LETTERS, 2004, 92 (1-2) : 15 - 22
  • [27] Applications of Bruton Tyrosine Kinase Inhibitors in Dermatology
    Whiting, Cleo
    Azim, Sara Abdel
    Friedman, Adam
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (08) : 697 - 698
  • [28] Bruton Tyrosine Kinase Inhibition in Dermatology and Allergology
    Wedi, B.
    HAUTARZT, 2018, 69 (06): : 519 - 522
  • [29] Bruton's Tyrosine Kinase in Ankylosing Spondylitis
    Liao, Hsien-Tzung
    Chen, Chun-Hsiung
    SPINE, 2024, 49 (10) : 677 - 681
  • [30] Targeting Bruton's Tyrosine Kinase in CLL
    Ahn, Inhye E.
    Brown, Jennifer R.
    FRONTIERS IN IMMUNOLOGY, 2021, 12